Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor.
A2A receptor
GPCR
MD simulations
in-silico
pharmacophore modeling
virtual screening.
Journal
Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
02
2019
accepted:
26
02
2019
pubmed:
9
3
2019
medline:
23
2
2020
entrez:
9
3
2019
Statut:
ppublish
Résumé
A2A receptor belongs to the family of GPCRs, which are the most abundant membrane protein family. Studies in the last few decades have shown the therapeutic applications of A2A receptor in various diseases. In the present mini-review, we have discussed the recent progress in the in-silico studies of the A2A receptor. Herein, we described the different structures of A2A receptor, the discovery of new agonists and antagonists using virtualscreening/ docking, pharmacophore modeling, and QSAR based pharmacophore modeling. We have also discussed various molecular dynamics (MD) simulations studies of A2A receptor in complex with ligands.
Identifiants
pubmed: 30848185
pii: CPD-EPUB-97118
doi: 10.2174/1381612825666190306162006
doi:
Substances chimiques
Adenosine A2 Receptor Agonists
0
Adenosine A2 Receptor Antagonists
0
Ligands
0
Receptor, Adenosine A2A
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
774-782Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.